US49177J1025 - Common Stock
KENVUE INC
NYSE:KVUE (11/18/2024, 4:18:39 PM)
After market: 23.82 +0.1 (+0.42%)23.72
-0.1 (-0.42%)
Kenvue, Inc. is a consumer health company. The company is headquartered in Skillman, New Jersey and currently employs 21,780 full-time employees. The company went IPO on 2023-05-04. The firm operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The firm has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
KENVUE INC
199 Grandview Road
Skillman NEW JERSEY
P: 17325240400
Employees: 21780
Website: https://www.kenvue.com
With a solid technical rating of 8 out of 10, KENVUE INC (NYSE:KVUE) is showing strong indications of a possible breakout.
KVUE earnings call for the period ending September 30, 2024.
Can tinkering around the edges actually make this stock more attractive?
Here you can normally see the latest stock twits on KVUE, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: